ArticleParasites & vectors2016
Countrywide serological evaluation of canine prevalence for Anaplasma spp., Borrelia burgdorferi (sensu lato), Dirofilaria immitis and Ehrlichia canis in Mexico.
Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Efficacy of Borrelia burgdorferi vaccine in dogs in North America: A systematic review and meta-analysis.Journal of veterinary internal medicine · 2019Pooled it
- Low observed perioperative complication rates associated with surgical sterilization of 1,011 heartworm-infected dogs using standard, unmodified anesthesia and surgical protocols.Parasites & vectors · 2026Article
- Seroprevalence ofVeterinary sciences · 2025Article
- Infections by Ehrlichia spp., Anaplasma spp. and Babesia spp. In Puerto Ordaz, Bolívar, VenezuelaBiomedica : revista del Instituto Nacional de Salud · 2025Article
- High seroprevalence of selected vector-borne pathogens in dogs from Saipan, Northern Mariana Islands.Parasites & vectors · 2025Article
- Clinical Study and Serological Diagnosis of Vector-Borne Pathogens in Sardinian Dogs.Veterinary sciences · 2024Article
- Serological investigation of seven zoonotic pathogens in companion dogs in South Korea, 2018-2021.Veterinary medicine and science · 2024Article
- Molecular Detection and Characterization ofLife (Basel, Switzerland) · 2023Article
- Geographical analysis of seroprevalence ofCurrent research in parasitology & vector-borne diseases · 2023Article
- A Case Study of Photosensitivity Associated withAnimals : an open access journal from MDPI · 2022Article
- Brown Dog Tick (International journal of environmental research and public health · 2022Article
- Serological and Molecular Evidence of Patients Infected withDiseases (Basel, Switzerland) · 2021Article
- Molecular Detection and Phylogeny ofAnimals : an open access journal from MDPI · 2021Article
- Epidemiological and Clinicopathological Features ofFrontiers in veterinary science · 2021Review
- Seroprevalence ofAnimals : an open access journal from MDPI · 2020Article
- Lyme disease and relapsing fever in Mexico: An overview of human and wildlife infections.PloS one · 2020Review
- A review on the occurrence of companion vector-borne diseases in pet animals in Latin America.Parasites & vectors · 2019Review
- Serological Survey ofPathogens (Basel, Switzerland) · 2019Article
- Seroprevalence and Current Infections of Canine Vector-Borne Diseases in Costa Rica.Frontiers in veterinary science · 2019Article
- Seroprevalence and current infections of canine vector-borne diseases in Nicaragua.Parasites & vectors · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCanine vector-borne diseases (CVBD) have become a major concern for canine and human public health. The aim of the study described here is to add epidemiological data regarding four pathogens responsible for CVBD, namely anaplasmosis, borreliosis, dirofilariosis and ehrlichiosis in a national survey conducted in Mexico.
methodsSeventy-four veterinary centres located in 21 federal Mexican states were asked to test dogs with clinical signs suspect for CVBD and healthy dogs, for detection of Dirofilaria immitis antigen and antibodies against Anaplasma spp., Borrelia burgdorferi (sensu lato) and Ehrlichia canis using the SNAP® 4DX® from IDEXX® Laboratories.
resultsA total of 1706 dogs were tested, including 943 apparently healthy and 722 CVBD-suspect dogs. Infected dogs were 36.7 %. The highest percentages of infection with E. canis (51.0 %) and Anaplasma spp. (16.4 %) were obtained in the northwestern region, while D. immitis was most frequently found in the northeastern region of the country (8.9 %). Four dogs from the northwestern, northeastern, eastern and southeastern regions, respectively, were positive for B. burgdorferi (sensu lato). Northcentral regions showed lowest overall prevalence of infection (2.4 %). Co-infections were detected in 8.8 % of the dogs tested. Statistically significant lower positivity was found among dogs aged less than one year (23.2 %) and small-sized dogs (27.6 %), while higher prevalence of infection was found in dogs living outdoors (42.0 %), dogs with detectable tick infestation (43.3 %) and dogs that received treatment for tick-transmitted infections (58.8 %). Seropositivity was a risk factor for the presence of clinical signs as follows: Anaplasma spp. (OR = 2.63; 95 % CI: 1.88-3.67; P < 0.0001), D. immitis (OR = 2.52; 95 % CI: 1.61-3.95; P < 0.0001), E. canis (OR = 3.58; 95 % CI: 2.88-4.45; P < 0.0001), mixed infections (OR = 4.08; 95 % CI: 2.79-5.96; P < 0.0001), one or more agents (OR = 3.58; 95 % CI: 2.91-4.42; P < 0.0001).
conclusionsCanine serological evidence supports that dogs from Mexico are at risk of acquiring Anaplasma spp., D. immitis and/or E. canis, while B. burgdorferi (sensu lato) transmission is minimal in the country. Practitioners play a fundamental role in the detection and control of these diseases to protect dogs and humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.